内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

前列腺癌根治术后辅助内分泌治疗热点问题和专家共识

2015-08-30 中华医学会泌尿外科学分会 中华泌尿外科杂志,2015,36(08):565-567.

前列腺癌内分泌治疗

随着我国前列腺癌诊断水平的不断提高，越来越多的患者在早期被发现，前列腺癌患者接受根治术的机会大大增加。目前，前列腺癌根治术后辅助内分泌治疗中遇到的主要问题有以下4点：①辅助内分泌治疗的适应证是什么？②辅助内分泌治疗何时开始？③辅助内分泌治疗的方案如何选择？④辅助内分泌治疗使用多久？因而前列腺癌根治手术术后如何规范地进行辅助内分泌治疗已经成为临床医生关注的热点。

中文标题：

前列腺癌根治术后辅助内分泌治疗热点问题和专家共识

发布机构：

中华医学会泌尿外科学分会

发布日期：

2015-08-30

简要介绍：

随着我国前列腺癌诊断水平的不断提高，越来越多的患者在早期被发现，前列腺癌患者接受根治术的机会大大增加。目前，前列腺癌根治术后辅助内分泌治疗中遇到的主要问题有以下4点：①辅助内分泌治疗的适应证是什么？②辅助内分泌治疗何时开始？③辅助内分泌治疗的方案如何选择？④辅助内分泌治疗使用多久？因而前列腺癌根治手术术后如何规范地进行辅助内分泌治疗已经成为临床医生关注的热点。

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191262, encodeId=ade8119126262, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:07:52 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149805, encodeId=82251498052f, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9341426471, createdName=yongninglu1981, createdTime=Wed Oct 19 23:29:09 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94187, encodeId=82fe9418e67, content=了解一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 20:15:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2022-02-08 1048467_6430

    太棒了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191262, encodeId=ade8119126262, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:07:52 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149805, encodeId=82251498052f, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9341426471, createdName=yongninglu1981, createdTime=Wed Oct 19 23:29:09 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94187, encodeId=82fe9418e67, content=了解一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 20:15:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2016-10-19 yongninglu1981

    学习一下！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191262, encodeId=ade8119126262, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:07:52 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149805, encodeId=82251498052f, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9341426471, createdName=yongninglu1981, createdTime=Wed Oct 19 23:29:09 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94187, encodeId=82fe9418e67, content=了解一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 20:15:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2016-07-22 1dd8c52fm63(暂无匿称)

    了解一下！

    0

相关指南

2014年CA新前列腺癌幸存者指南

美国癌症学会(ACS,American Cancer Society) · 2016-04-20

2015 ASCO临床实践指南：前列腺癌生存者护理指南

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2015-02-09

2014 SIOG推荐建议：老年前列腺癌的管理（更新版）

国际老年肿瘤学会(SIOG,International Society of Geriatric Oncology) · 2014-08-15

2014 ISUP共识会议：前列腺癌进行免疫组化检查的最佳实践建议

国际泌尿病理学会(ISUP,International Society of Urological Pathology) · 2014-08-01

2014 前列腺癌MR检查和诊断共识

中华放射学杂志编辑委员会 · 2014-07-30

2014年美国癌症学会前列腺癌幸存者临床指南

美国癌症学会(ACS,American Cancer Society) · 2014-06-10